Matthew Turner serves as President of Patient Affordability at PAYSIGN INC., where he leads initiatives to enhance access to life-saving medications and therapies through innovative payment solutions. With over 20 years of experience in healthcare finance and patient support services, Turner has built a distinguished career focused on bridging the gap between pharmaceutical innovation and patient affordability. Prior to joining PAYSIGN, he held executive roles at leading copay assistance organizations, including Vice President of Program Development at a major patient access firm, where he scaled national programs serving millions of patients annually. Turner's achievements include pioneering data-driven affordability models that reduced out-of-pocket costs by up to 40% for chronic disease patients, earning him recognition as a Healthcare Financial Innovator by Modern Healthcare in 2022. He has successfully launched over 50 patient assistance programs, partnering with top biopharma companies to distribute billions in savings. At PAYSIGN, Turner oversees the Patient Affordability division, leveraging the company's prepaid card technology and proprietary platforms to deliver seamless, compliant solutions that minimize administrative burdens and maximize reimbursement efficiency. Under Turner's leadership, PAYSIGN's affordability programs have expanded to cover rare diseases and oncology treatments, achieving a 25% year-over-year growth in enrollment. His strategic vision emphasizes equity in healthcare access, integrating AI analytics to predict and prevent coverage gaps, positioning PAYSIGN as a leader in the evolving landscape of value-based care.